	US 12,227,485 B2
	Compounds useful for the treatment of infection with Mannheimia haemolytica or Histophilus somni
Thorsten Meyer, Wiesbaden (DE); Michael Berger, Wiesbaden (DE); Ralf Warrass, Alzey (DE); and Joachim Ullrich, Stadecken-Elsheim (DE)
Assigned to Intervet Inc., Rahway, NJ (US)
Appl. No. 17/253,346
Filed by Intervet Inc., Madison, NJ (US)
PCT Filed Jun. 24, 2019, PCT No. PCT/EP2019/066667 § 371(c)(1), (2) Date Dec. 17, 2020, PCT Pub. No. WO2020/002234, PCT Pub. Date Jan. 2, 2020.
Claims priority of application No. 18179616 (EP), filed on Jun. 25, 2018.
Prior Publication US 2021/0292284 A1, Sep. 23, 2021
Int. Cl. C07D 239/94 (2006.01); A61P 11/00 (2006.01); A61P 31/04 (2006.01); C07D 217/22 (2006.01); C07D 275/04 (2006.01)

CPC C07D 239/94 (2013.01) [A61P 11/00 (2018.01); A61P 31/04 (2018.01); C07D 217/22 (2013.01); C07D 275/04 (2013.01)]

5 Claims

1. A compound of Formula A

OG Complex Work Unit Chemistry

wherein

A is cyclopropylamine,

R¹is CH(CH₃)OH,

Y2 is S, and

qY3 is 0.